Changing Diabetes in Children (CDiC)

Novo Nordisk

Status: Terminated

Conditions: Diabetes Mellitus, Type 1; Diabetes

Treatments: Drug: insulin human

Study type: Observational

Funder types: Industry

Identifiers

NCT02382757

INS-3982

U1111-1149-2666 (Other Identifier)

Details and patient eligibility

About

This study is conducted in Asia. The primary objective of the CDiC programme is to improve access to comprehensive diabetes care among the children with diabetes from the economically underprivileged section of the population and to establish a registry for this group of children with type 1 diabetes in India.

Enrollment: 3,089 patients

Sex: All

Ages: Under 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children diagnosed with type 1 diabetes
• Parents/caretakers agree to participate in the study
• Child belongs to the below poverty line economic strata (Centre Director certifies economic status for inclusion in to the study)

Exclusion criteria

• Children with type 2 diabetes
• Children from higher economic status
• Those getting coverage under other government / private schemes

Trial design

3,089 participants in 1 patient group

Children

Treatment:

Drug: insulin human